After the start of the pandemic, the U.S. Food and Drug Administration approved advanced manufacturing for two drugs to treat COVID-19, according to the report from the U.S. Government Accountability Office .Congress examines support for caregivers as millions rely on home & community-based care
“There is a lot of uncertainty around this given it is a new technology,” said Mary Denigan-Macauley, a Director of Public Health for GAO. “Traditional ways of producing drugs for example can be much slower,” Denigan-Macauley said. “They’re producing batches and they can take months to do but if you can do an advanced technology called continuous manufacturing, you can be able to produce them in a few days. So, if you end up with supply problems like you saw in COVID-19, this can be pretty revolutionary.”